ALLERGY CONTROL DESLORATADINE TABLET

Страна: Канада

мова: англійська

Джерело: Health Canada

Активний інгредієнт:

DESLORATADINE

Доступна з:

PHARMASCIENCE INC

Код атс:

R06AX27

ІПН (Міжнародна Ім'я):

DESLORATADINE

Дозування:

5MG

Фармацевтична форма:

TABLET

Склад:

DESLORATADINE 5MG

Адміністрація маршрут:

ORAL

Одиниць в упаковці:

10/20/30/50/100/120/180

Тип рецепту:

OTC

Терапевтична области:

SECOND GENERATION ANTIHISTAMINES

Огляд продуктів:

Active ingredient group (AIG) number: 0143961001; AHFS:

Статус Авторизація:

APPROVED

Дата Авторизація:

2013-11-26

Характеристики продукта

PRODUCT MONOGRAPH
ALLERGY CONTROL DESLORATADINE
Desloratadine tablets
5 mg
Histamine H
1
-Receptor Antagonist
PHARMASCIENCE INC.
6111 Royalmount Avenue, Suite 100
Montréal, Canada
H4P 2T4
Date of Preparation:
November 5, 2013
Submission Control No: 169400
_ _
_ALLERGY CONTROL DESLORATADINE Product Monograph _
_Page 2 of 33_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................7
OVERDOSAGE
..................................................................................................................8
ACTION AND CLINICAL PHARMACOLOGY
..............................................................8
STORAGE AND STABILITY
..........................................................................................11
SPECIAL HANDLING INSTRUCTIONS
.......................................................................11
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................11
PART II: SCIENTIFIC INFORMATION
...............................................................................12
PHARMACEUTICAL INFORMATION
..........................................................................12
CLINICAL TRIALS
....................................................